-
Mashup Score: 0The Clinical Impact of the ADAPTABLE Trial - 3 year(s) ago
W. Schuyler Jones, MD, and Manesh Patel, MD discuss the influences the aspirin-dosing cardiology trial may have on future studies.
Source: HCPLiveCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Young Black women have health conditions that may put them at greater risk to develop heart disease, according to a study released Tuesday by a team of Emory University researchers.
Source: ajcCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1REDUCE-IT EPA Trial Shows Association Between Higher EPA Levels, Reduced CV Events - American College of Cardiology - 3 year(s) ago
A reduction in cardiovascular events and deaths among patients taking the prescription fish oil icosapent ethyl may be associated with higher blood levels of the omega-3 fatty acid eicosapentaenoic acid (EPA), according to findings from a REDUCE-IT substudy presented in a Late-Breaking Clinical Trial Session on March 30 during ACC.20/WCC. Deepak L. Bhatt, MD, MPH, FACC, et al., previously…
Source: American College of CardiologyCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0FDA Approves Vericiguat for High-risk Patients With HF - 3 year(s) ago
The approval, the first from the FDA in 2021, follows the positive results from the VICTORIA trial presented last year at ACC.
Source: TCTMD.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Bacon Ingredient Disappoints in Out-of-Hospital Cardiac Arrest - 3 year(s) ago
Repurposed as drug, tested in randomized trial
Source: www.medpagetoday.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5
Without a doubt, the top news of 2020 was the COVID-19 pandemic. From the beginning, ACC was at the forefront of generating clinical guidance, providing expert commentary and facilitating the sharing of new research and front-line perspectives. Top articles include Cardiology magazine features on the risk of infectious agents and an exclusive interview with…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4INVESTED: High-Dose Trivalent Influenza Vaccine vs. Standard Quadrivalent Vaccine in CV Patients - American College of Cardiology - 3 year(s) ago
A high-dose, trivalent influenza vaccine was no more effective than the standard-dose quadrivalent vaccine at reducing the risk of death or hospitalization for heart or lung-related causes among high-risk cardiovascular patients, according to findings from the INVESTED trial presented Nov. 17 during AHA 2020. Researchers randomized 5,260 patients from 157…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Medtronic announced that the FDA approved an expanded indication for a drug-eluting stent to include patients with high bleeding risk who take dual antiplatelet therapy for 1 month after PCI.The DES (Resolute Onyx) is the first and only stent in the U.S. that is safe and effective in this particular patient population, according to a press release from the company.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Heart failure (HF) is a leading cause of morbidity…
Source: European Medical JournalCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
A phase 3 pivotal trial of MyoKardia’s mavacamten has demonstrated that the first-in-class drug can perform as a disease-specific therapy for hypertrophic cardiomyopathy, or HCM, by preventing the thickened heart muscle associated with the disease from obstructing the flow of blood.
Source: FierceBiotechCategories: Cardiology News and Journals, Latest HeadlinesTweet
Data from the #ADAPTABLE trial was presented at #ACC20 this year. HCPLive spoke with @schuyler_jones about the biggest takeaways from the study on Ep 1 of the #HeartTrials podcast. How might this trial potentially influence future clinical trials? https://t.co/1aE8dDL6tj https://t.co/DwLBvVYpKe